slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 64,621-64,650
Pages 2,605
Rows per page 30
Component
64,621-64,650 of 78,138
36
The slide combines a biological mechanism diagram with clinical trial data (table and line chart) to validate the drug's mechanism of action.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
37
Swimmer plot showing days on study for three patients, with corresponding CT scan imagery for one patient.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
05
The slide uses a timeline framework to demonstrate long-term IP protection.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
13
The slide establishes a baseline for FXN levels in healthy individuals to contextualize the deficiency seen in Friedreich's Ataxia (FA) patients.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
40
Kaplan-Meier survival curve showing efficacy of FXN replacement therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
08
The chart shows a stacked bar breakdown of U.S. vs EU sales over 6 quarters.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The chart illustrates a net decrease of $2M ($147M to $145M) driven by R&D savings offset by SG&A and Admin increases.Legend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The slide uses a three-column layout to represent the pillars of the business strategy.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a maturity model framework to show the transition from Limbach 1.0 to 3.0.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue growth.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Includes a bar chart comparing FY2021 and FY2022 revenue and a list of key financial highlights.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Beat · Financials1 hit
08
Lion Electric | Results Presentation Deck | 21 slidesLion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Beat · Product1 hit
07
The slide uses a timeline to show strategic milestones and pie charts to show revenue composition changes over time.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
13
Includes a table of revenue growth drivers and a stacked bar chart showing revenue mix.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
14
The chart uses a standard waterfall format to bridge beginning cash to ending cash.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
15
Includes YTD 2023 full year outlook projections.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
19
The chart uses a standard waterfall bridge format to explain the variance in EPS guidance.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
28
Includes a combo chart showing revenue, EBITDA, and EBITDA margin trend.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
29
Includes a map of locations, a table of operational metrics, a list of competitors, and a stacked bar chart of revenue.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Competition1 hit
48
Includes a line chart for commodity prices and three tables detailing EBITDA impacts and FX rates.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
05
The slide uses a Gantt-style layout to represent drug development stages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a visual comparison of population growth to frame the problem of age-related cancer.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Solution1 hit
12
The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
19
Clinical trial data visualization showing patient-level outcomes over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
20
The chart tracks individual patient outcomes over time, including treatment status, response type, and study exit reasons.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
21
The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
22
The slide provides visual and quantitative evidence of the drug's mechanism of action (MOA) by showing the increase of TIFs over 72 hours.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
29
The chart shows tumor volume over time, with the THIO group reaching 100% complete response (CR).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
36
The chart compares the combined market size of major CPIs ($42B) against Libtayo ($0.5B) to illustrate the growth potential.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pareto Focus1 hit
38
The slide uses a growth curve background to imply value accumulation over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit